首页> 外文期刊>Journal of Veterinary Advances >The Pattern of Immunomodulation of ImmuPlus on the Infectious Bursal Disease (IBD) Antibody of Vaccinated Broiler Chickens
【24h】

The Pattern of Immunomodulation of ImmuPlus on the Infectious Bursal Disease (IBD) Antibody of Vaccinated Broiler Chickens

机译:ImmuPlus对疫苗接种肉鸡传染性法氏囊病(IBD)抗体的免疫调节模式

获取原文
       

摘要

The pattern of immunomodulation of immuplusR on the IBD antibody of vaccinated broiler chicken was investigated in this 70 day study. ImmuplusR, a polyherbal formulation from Ayurved is purported to posses immunomodulatory properties. Ninety nine day old chicks divided into groups A, B, C were used for the study. Two groups, A and B were placed under Immuplus, while group C served as the control. Group A was placed on pulse administration of ImmuPlusR, via drinking water, daily, for 10 days at a 10 day interval from day 8 to day 70. Group B was placed on daily oral administration of ImmuPlusR for the same duration of time. Group C was placed on water only, throughout the experiment. Twelve chickens were bled from each group and the sera harvested for enzyme-linked immunosorbent assay (ELISA) in the evaluation of IBD antibody levels on a weekly basis. The weekly mean values of ELISA results obtained thus were subjected to one-way analysis of variance (ANOVA)and Duncan's multiple range test (DMRT).The treatment groups showed superior antibody response to the control groups for most of the week with significant differences (P<0.05) on the 6th'8th and 10th weeks.The pulse treatment group exhibited inconsistent antibody response. Daily administration was found to enhance their antibody response to gumboro disease and may therefore be useful in its control. It appeared to have a slow onset of action and low residual effect hence the pulse administration of the supplement may not produce a good result.
机译:在这项为期70天的研究中,研究了免疫肉鸡IBD抗体上immuplusR的免疫调节模式。 ImmuplusR(一种来自Ayurved的多草药制剂)据称具有免疫调节特性。分为A,B,C组的99只大龄小鸡用于研究。将两组A和B置于Immuplus下,而C组作为对照。从第8天到第70天,以每天10天的间隔,每天通过饮用水对A组进行ImmuPlusR脉冲给药,持续10天。对B组进行相同时间的每日口服ImmuPlusR给药。在整个实验过程中,C组仅放置在水上。从每组中抽出十二只鸡,每周收集血清用于酶联免疫吸附测定(ELISA),以评估IBD抗体水平。将由此获得的ELISA结果的每周平均值进行单向方差分析(ANOVA)和Duncan多范围检验(DMRT)。治疗组在一周的大部分时间内显示出优于对照组的抗体反应,差异有统计学意义(在第6、8和10周P <0.05)。脉冲治疗组表现出不一致的抗体应答。发现每日给药可增强其对牙龈疾病的抗体反应,因此可能在控制中有用。它似乎起效缓慢,残留效果低,因此,脉冲给药补充剂可能不会产生好的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号